Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Think Research Corporation THKKF


Primary Symbol: V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.


TSXV:THNK - Post by User

Comment by dt_coreon Feb 16, 2024 8:29am
110 Views
Post# 35883741

RE:RE:RE:Investor relations rating

RE:RE:RE:Investor relations ratingWell there you have it. I knew something had to give by mid month and dissapointed to see that my concern about an MBO has now come to fruition.

So how should shareholder vote? We've had poor disclosure and also what now appears to be false and misleading statement by management during conference calls, and a management team that is trying to save their hides (jobs) after destroying shareholder value on an incredible scale. But .32 seems like highway robbery and given its Beedie we have a firm that has privaledged insider information in making its decision regarding items such as pipeline and backlog that investors don't have quantitative numbers to assess, just fluffy comments. I am quite certain that Beedie expects to make out like bandits on this deal. All this feels like an investor lawsuit in the making.

I fully expect other suitors to kick the tires here and in particular I think WellHealth (WELL:TSX) will want to make a bid. Given that my view is that .32 per share is the opening bid. How high those bids could go is anybody's guess but if the company does sell at .32 then it'll be crystal clear that SA has flat out made false statements.
<< Previous
Bullboard Posts
Next >>